NanoString Technologies Inc

NSTG
0,1053
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/4/202423:25EDGAR2Form 8-K - Current report
19/4/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/4/202422:11EDGAR2Form 8-K - Current report
22/3/202421:00EDGAR2Form 8-K - Current report
15/3/202421:01EDGAR2Form NT 10-K - Notification of inability to timely file Form..
14/2/202423:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202403:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202412:30BWNanoString Announces Completion of Financing to Support..
08/2/202416:45EDGAR2Form 8-K - Current report
05/2/202412:01EDGAR2Form 8-K - Current report
05/2/202401:45BWNanoString Takes Steps to Restructure Its Business and..
01/2/202412:00BWNanoString Launches the CosMx 6,000 plex RNA Assay and..
25/1/202423:01EDGAR2Form 8-K - Current report
25/1/202417:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/1/202421:00BWNanoString’s CosMx SMI Achieves Whole Transcriptome Imaging..
05/1/202422:01BWNanoString Reports Inducement Grants Under Nasdaq Listing..
05/1/202412:02EDGAR2Form 8-K - Current report
04/1/202412:00BWNanoString to Webcast Presentation from 42nd Annual J.P...
01/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
30/11/202322:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/11/202322:31EDGAR2Form S-3 - Registration statement under Securities Act of..
20/11/202312:08EDGAR2Form 8-K - Current report
20/11/202300:16BWNanoString Comments on Delaware District Court Verdict
09/11/202318:00BWNanoString Technologies to Present Portfolio of Cutting-edge..
09/11/202312:00BWNanoString to Webcast Presentations from Upcoming Healthcare..
07/11/202322:10EDGAR2Form 8-K - Current report
06/11/202323:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:11EDGAR2Form 8-K - Current report
06/11/202322:00BWNanoString Technologies Releases Operating Results for Third..
01/11/202310:00BWNanoString Customers Present First Data Using the Most..
10/10/202318:06PRNUS10x Genomics Comments on Second UPC Preliminary Injunction..
10/10/202312:00BWNanoString Provides Preliminary Financial and Operational..
03/10/202312:00BWA*STAR’s Genome Institute of Singapore, NanoString and Next..
19/9/202319:08PRNUS10x Wins Injunction From Unified Patent Court Banning Sales..
19/9/202317:54BWNanoString Comments on Unified Patent Court Order
14/9/202312:00BWNanoString to Host Virtual Spatial Genomics Summit September..
13/9/202312:00BWNanoString Launches the Most Comprehensive Spatial..
12/9/202312:02EDGAR2Form 8-K - Current report
07/9/202312:01EDGAR2Form 8-K - Current report
07/9/202312:00BWNanoString Expands Partnerships with Contract Research..
05/9/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202312:00BWNanoString to Webcast Presentations from Upcoming Healthcare..
01/9/202314:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/8/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202311:53BWNanoString Appoints Todd Garland as Chief Commercial Officer
21/8/202321:29EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/8/202312:00BWNanoString Platforms Advance Groundbreaking Studies of..
Apertura: Min: Max:
Chiusura: 0,1053

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network